BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 25607708)

  • 1. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE; Pollak RA; Pillai R; Olin JT
    J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
    Cantrell W; Canavan T; Elewski B
    J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
    Cook-Bolden FE; Lin T
    Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC; Joseph WS
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P
    J Drugs Dermatol; 2015 Jan; 14(1):58-62. PubMed ID: 25607909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment of onychomycosis with efinaconazole solution 10%.
    Rich P
    Cutis; 2013 Jun; 91(6):305-7. PubMed ID: 23837154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and
    Lee BC; Pangeni R; Na J; Koo KT; Park JW
    Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
    Gupta AK; Cooper EA
    Skin Therapy Lett; 2021 Jan; 26(1):5-10. PubMed ID: 33539062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
    Tosti A
    Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
    Jellinek NJ; Korotzer A
    J Drugs Dermatol; 2015 Aug; 14(8):871-5. PubMed ID: 26267732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.